IGM Biosciences's total assets for Q1 2025 were $206.89M, a decrease of -22.14% from the previous quarter. IGMS total liabilities were $206.19M for the fiscal quarter, a -5.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.